knowledge -WSS

knowledge

author：explore 2025-09-30 20:47:22 - browse：5643

Jamy Ard (left) and Robert Lustig (right) on the 2023 STAT Breakthrough Summit stage -- coverage from STAT — Obesity experts Jamy Ard (left) and Robert Lustig speak at a panel during the 2023 STAT Breakthrough Summit. Sarah Gonzalez for STAT

Amid rising demand for drugs like Wegovy, Ozempic, and Mounjaro that can lead to significant weight loss, some obesity experts are concerned about the drugs’ costs — both to patients’ finances and to their health.

Speaking at a panel on new obesity treatments at the STAT Breakthrough Summit in San Francisco on Thursday, one expert cited a large clinical trial for Wegovy that showed that about 40% of the weight participants lost was lean mass. Side effects like nausea, vomiting, and a possible link to rare cases of pancreatitis also still plague this newest class of drugs, which imitate the effects of a hormone called glucagon-like peptide 1 (GLP) that helps people feel full.

“That’s what starvation does. You lose equal amounts of muscle and fat,” said Robert Lustig, emeritus professor of pediatrics at the University of California, San Francisco. “If you’re a person 60 years old or over and you’re losing muscle, your risk of dying just went up exponentially. So we may be … robbing Peter to pay Paul.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： Listen: Biogen's messy board & Laronde's data problem

leisure time

WSS

Sickle cell gene therapy cures need to be accessible in Africa

4th of July breaks record for highest global temperature ever measured

Superbugs, antibiotic resistance get scrutiny in congress

A new study asks: Are we harming blood donors by taking blood?

Can food be medicine? And other questions about a new push

Tornado touches down near Chicago's O'Hare airport amid extreme weather nationwide

leisure time

knowledge

hotspot

Moonlake's readout produced a cash windfall. Risks remain

Tornado touches down near Chicago's O'Hare airport amid extreme weather nationwide

How to save PrEP access — and even expand it

Why is France rioting? What to know about the fatal police shooting of Nahel M

Hollywood unions extend contract negotiations for actors

These geoengineering technologies could help combat the climate crisis, scientists say

Walensky prepares to leave CDC — and Congress — behind

Blinken talks high

In Memoriam: Notable people who died in 2023

How are insurers handling Leqembi and related scans?

focus

Grail's uphill battle for Medicare to cover its cancer screening test

Inflation cooled significantly in June, bringing price hikes close to normal levels

7 people shot in DC, police say

Brain 'hot spot' may explain why African Americans feel greater pain

Watch the official trailer for 'Ahsoka' series

Is there an 'orca uprising'? Like orcas themselves, the answer is complex.

explore

focus

leisure time

focus